These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 29110611)

  • 21. Evaluation of the Effect of Everolimus on Retinal Pigment Epithelial Cells and Experimental Proliferative Vitreoretinopathy.
    Kuo HK; Chen YH; Kuo YH; Ke MC; Tseng YC; Wu PC
    Curr Eye Res; 2018 Mar; 43(3):333-339. PubMed ID: 29182404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Snail involves in the transforming growth factor β1-mediated epithelial-mesenchymal transition of retinal pigment epithelial cells.
    Li H; Wang H; Wang F; Gu Q; Xu X
    PLoS One; 2011; 6(8):e23322. PubMed ID: 21853110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blockade of Jagged/Notch pathway abrogates transforming growth factor β2-induced epithelial-mesenchymal transition in human retinal pigment epithelium cells.
    Chen X; Xiao W; Liu X; Zeng M; Luo L; Wu M; Ye S; Liu Y
    Curr Mol Med; 2014 May; 14(4):523-34. PubMed ID: 24694299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long noncoding RNA ERLR mediates epithelial-mesenchymal transition of retinal pigment epithelial cells and promotes experimental proliferative vitreoretinopathy.
    Yang S; Li H; Yao H; Zhang Y; Bao H; Wu L; Zhang C; Li M; Feng L; Zhang J; Zheng Z; Xu G; Wang F
    Cell Death Differ; 2021 Aug; 28(8):2351-2366. PubMed ID: 33664479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression p21WAF1/CIP1 in suppressing retinal pigment epithelial cells and progression of proliferative vitreoretinopathy via inhibition CDK2 and cyclin E.
    Wang Y; Yuan Z; You C; Han J; Li H; Zhang Z; Yan H
    BMC Ophthalmol; 2014 Nov; 14():144. PubMed ID: 25421815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BMP7 antagonizes proliferative vitreoretinopathy through retinal pigment epithelial fibrosis in vivo and in vitro.
    Yao H; Ge T; Zhang Y; Li M; Yang S; Li H; Wang F
    FASEB J; 2019 Mar; 33(3):3212-3224. PubMed ID: 30383450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone morphogenetic protein 6 (BMP6) antagonises experimental proliferative vitreoretinopathy established by TGF-β2 stimulation in retinal pigment epithelial cells through modulation of the p38 and JNK MAPK pathways.
    Liu X; Liu M; Chen L
    Cell Tissue Res; 2024 Apr; 396(1):103-117. PubMed ID: 38403744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exosomes mediate an epithelial-mesenchymal transition cascade in retinal pigment epithelial cells: Implications for proliferative vitreoretinopathy.
    Zhang Y; Wang K; Pan J; Yang S; Yao H; Li M; Li H; Lei H; Jin H; Wang F
    J Cell Mol Med; 2020 Nov; 24(22):13324-13335. PubMed ID: 33047885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Knockdown of HSPA13 Inhibits TGFβ1-Induced Epithelial-Mesenchymal Transition of RPE by Suppressing the PI3K/Akt Signaling Pathway.
    Gao F; Li M; Zhu L; Li J; Xu J; Jia S; Ou Q; Jin C; Tian H; Wang J; Xu J; Xu W; Xu GT; Lu L
    Invest Ophthalmol Vis Sci; 2024 Sep; 65(11):1. PubMed ID: 39226050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitory Effects of Plumbagin on Retinal Pigment Epithelial Cell Epithelial-Mesenchymal Transition In Vitro and In Vivo.
    Chen H; Wang H; An J; Shang Q; Ma J
    Med Sci Monit; 2018 Mar; 24():1502-1510. PubMed ID: 29532788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Knockdown of survivin results in inhibition of epithelial to mesenchymal transition in retinal pigment epithelial cells by attenuating the TGFβ pathway.
    Zhang P; Zhao G; Ji L; Yin J; Lu L; Li W; Zhou G; Chaum E; Yue J
    Biochem Biophys Res Commun; 2018 Apr; 498(3):573-578. PubMed ID: 29522718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel NADPH oxidase inhibitor VAS2870 suppresses TGF‑β‑dependent epithelial‑to‑mesenchymal transition in retinal pigment epithelial cells.
    Yang J; Li J; Wang Q; Xing Y; Tan Z; Kang Q
    Int J Mol Med; 2018 Jul; 42(1):123-130. PubMed ID: 29620174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The polyether ionophore salinomycin targets multiple cellular pathways to block proliferative vitreoretinopathy pathology.
    Heffer AM; Proaño J; Roztocil E; Phipps RP; Feldon SE; Huxlin KR; Sime PJ; Libby RT; Woeller CF; Kuriyan AE
    PLoS One; 2019; 14(9):e0222596. PubMed ID: 31527897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombin induces epithelial-mesenchymal transition and collagen production by retinal pigment epithelial cells via autocrine PDGF-receptor signaling.
    Bastiaans J; van Meurs JC; van Holten-Neelen C; Nagtzaam NM; van Hagen PM; Chambers RC; Hooijkaas H; Dik WA
    Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):8306-14. PubMed ID: 24302586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epithelial-mesenchymal transition suppresses ERas to activate autophagy in retinal pigment epithelial cells in proliferative vitreoretinopathy.
    Pan J; Zhao LX
    Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4627-4634. PubMed ID: 32432726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DAPL1 prevents epithelial-mesenchymal transition in the retinal pigment epithelium and experimental proliferative vitreoretinopathy.
    Ma X; Han S; Liu Y; Chen Y; Li P; Liu X; Chang L; Chen YA; Chen F; Hou Q; Hou L
    Cell Death Dis; 2023 Feb; 14(2):158. PubMed ID: 36841807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nintedanib inhibits normal human vitreous-induced epithelial-mesenchymal transition in human retinal pigment epithelial cells.
    Yin Y; Liu S; Liu H; Wu W
    Biomed Pharmacother; 2023 Oct; 166():115403. PubMed ID: 37659204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Substance P prevents development of proliferative vitreoretinopathy in mice by modulating TNF-α.
    Yoo K; Son BK; Kim S; Son Y; Yu SY; Hong HS
    Mol Vis; 2017; 23():933-943. PubMed ID: 29296073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activated Blood Coagulation Factor X (FXa) Contributes to the Development of Traumatic PVR Through Promoting RPE Epithelial-Mesenchymal Transition.
    Han H; Zhao X; Liao M; Song Y; You C; Dong X; Yang X; Wang X; Huang B; Du M; Yan H
    Invest Ophthalmol Vis Sci; 2021 Jul; 62(9):29. PubMed ID: 34283209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Silencing the long noncoding RNA MALAT1 inhibits vitreous-induced epithelial-mesenchymal transition in RPE cells by regulating the PDGFRs/AKT axis.
    Yang G; Huang Y; Li D; Tang J; Li W; Huang X
    Int Ophthalmol; 2024 Sep; 44(1):363. PubMed ID: 39227412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.